![Medtronic Receives CE Mark Approval for Viva CRT-P Medtronic Receives CE Mark Approval for Viva CRT-P](https://images.medindia.net/health-images/1200_1000/icd.jpg)
The company added that other tools such as OptiVol Fluid Status Monitoring and Cardiac Compass Report also feature in the device, providing an accurate assessment of rehospitalization risk within 30 days of discharge. While Viva CRT-P has been approved it Europe, it is yet to gain approval from the US Food and Drug Administration.
“The diagnostic capabilities of this smart device help improve function throughout the continuum of care. This represents a win for both patients and physicians and, when coupled with additional longevity, provides another layer of distinct value over a longer period”, Medtronic’s David Steinhaus said.
Source-Medindia